CDH2 and renal cell carcinoma: In addition to E-cadherin, N-cadherin (also known as cadherin 2, CDH2), which is a mesenchymal marker, is differently expressed in RCC and EMT progression (Behnes et al., 2012; Alimperti and Andreadis, 2015).